Stockreport

Inhibikase Therapeutics GAAP EPS of -$0.65 misses by $0.17 [Seeking Alpha]

Inhibikase Therapeutics, Inc.  (IKT) 
PDF More on Inhibikase Therapeutics Inhibikase Therapeutics stock rises after pricing $110M private offering Seeking Alpha's Quant Rating on Inhibikase Therapeutics H [Read more]